Can inhibition of IKur promote atrial fibrillation?

被引:41
作者
Burashnikov, Alexander [1 ]
Antzelevitch, Charles [1 ]
机构
[1] Masonic Med Res Lab, Utica, NY 13501 USA
关键词
atrial fibrillation; antiarrhythmic agents; action potential;
D O I
10.1016/j.hrthm.2008.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Block of ultrarapid delayed rectified potassium current (I-Kur), present in atria but not in ventricles, is thought to be a promising approach for atrial-specific therapy of atrial fibrillation (AF). However, it has been shown that I-Kur block may abbreviate atrial repolarization and that Loss-of-function mutations in KCNA5, which encodes K-v 1.5 channels responsible for I-Kur is associated with familial AF. OBJECTIVE Our objective in this study was to use low concentrations of 4-aminopyridine (4-AP, 10 to 50 mu M), known to selectively block I-Kur to assess the proarrhythmic and antiarrhythmic effects of I-Kur block in healthy and remodeled atria. METHODS Isolated canine coronary-perfused right atrial preparations were used. Acetylcholine or ischemia/reperfusion was used to acutely remodel the atria. Transmembrane action potentials and a pseudo-etectrocardiogram were simultaneously recorded. RESULTS Normal (healthy) atria typically displayed action potentials (AP) with a prominent plateau, whereas remodeled atria displayed triangular-shaped APs (remodeled). In healthy atria, in which AF could not be induced with programmed stimulation, 4-AP abbreviated action potential measured at 90% repolarization (APD(90)) and effective refractory period (ERP), permitting the induction of AF in 4 of 12 preparations (33%). In remodeled atria, 4-AP produced Little (50 mu M) to no (10 to 25 mu M) prolongation of APD(90) or ERP and was either ineffective or poorly effective in terminating AF or preventing its induction. CONCLUSION Our findings suggest that block of I-Kur can provide the substrate for development of AF in healthy canine atria, presumably via abbreviation of APO and ERP.
引用
收藏
页码:1304 / 1309
页数:6
相关论文
共 41 条
[11]   KINETICS OF ONSET OF RATE-DEPENDENT EFFECTS OF CLASS-I ANTI-ARRHYTHMIC DRUGS ARE IMPORTANT IN DETERMINING THEIR EFFECTS ON REFRACTORINESS IN GUINEA-PIG VENTRICLE, AND PROVIDE A THEORETICAL BASIS FOR THEIR SUBCLASSIFICATION [J].
CAMPBELL, TJ .
CARDIOVASCULAR RESEARCH, 1983, 17 (06) :344-352
[12]   Characterization of the in vivo and in vitro electrophysiological effects of the novel antiarrhythmic agent AZD7009 in atrial and ventricular tissue of the dog [J].
Carlsson, L ;
Chartier, D ;
Nattel, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (01) :123-132
[13]   Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 1999, 42 (02) :477-489
[14]   The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans [J].
Dorian, Paul ;
Pinter, Arnold ;
Mangat, Iqwal ;
Korley, Victoria ;
Cvitkovic, Suzan S. ;
Beatch, Gregory N. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (01) :35-40
[15]   Characterization of human cardiac kv1.5 inhibition by the novel atria I-selective antiarrhythmic compound AVE1231 [J].
Ehrlich, Joachim R. ;
Ocholla, Hellen ;
Ziemek, Daniel ;
Ruetten, Hartmut ;
Hohnloser, Stefan H. ;
Goegelein, Heinz .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (04) :380-387
[16]   The mechanism of atrial antiarrhythmic action of RSD1235 [J].
Fedida, D ;
Orth, PMR ;
Chen, JYC ;
Lin, SP ;
Plouvier, B ;
Jung, G ;
Ezrin, AM ;
Beatch, GN .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (11) :1227-1238
[17]   Ultrarapid delayed rectifier current inactivation in human atrial myocytes: properties and consequences [J].
Feng, JL ;
Xu, DH ;
Wang, ZG ;
Nattel, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05) :H1717-H1725
[18]   Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels [J].
Gögelein, H ;
Brendell, J ;
Steinmeyer, K ;
Strübing, C ;
Picard, N ;
Rampe, D ;
Kopp, K ;
Busch, AE ;
Bleich, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (03) :183-192
[19]   AZD7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model [J].
Goldstein, RN ;
Khrestian, C ;
Carlsson, L ;
Waldo, AL .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (12) :1444-1450
[20]  
Knobloch K, 2004, MED SCI MONITOR, V10, pBR221